Concepedia

Shahad Alsadik

SA

Statistics

Publications

2

Citations

32

H-Index

2

Active since

2022

Affiliations

Sun Yat-sen University(Current)

Royal Free London NHS Foundation Trust

Shahad Alsadik is an author at Sun Yat-sen University specializing in renal disease, oncologic nuclear medicine, and impaired kidney function.

ORCID

Publications per year

2022–2022

2

Publications

2

Safety of Peptide Receptor Radionuclide Therapy with <sup>177</sup>Lu-DOTATATE in Neuroendocrine Tumor Patients with Chronic Kidney Disease

Shahad Alsadik, Gopinath Gnanasegaran, Luohai Chen et al. · Journal of Nuclear Medicine · 2022 · 20 citations · Full text

, , +17

Single centre retrospective review of outcome of <scp> <sup>177</sup> Lu‐DOTATATE </scp> peptide receptor radionuclide therapy in the treatment of progressive metastatic neuroendocrine tumours: Survival, toxicity, and prognostic factors

Shahad Alsadik, Gopinath Gnanasegaran, Luohai Chen et al. · Journal of Neuroendocrinology · 2022 · 12 citations

, , +17

1–2 of 2